Year: 2017
Type: article
Study design: Observational Study
Abstract: Chromosomal microarrays have been used for over a decade to improve clinical diagnostic rates by identifying copy number variations (CNVs) across the genome.CNVs in noncoding regions of the genome are difficult to interpret because less is understood about the etiology of disease in these cases.Topologically-associating domains (TADs) describe the higher order chromatin structure that creates a landscape for enhancer-promoter interaction.The human genome has roughly two thousand such regions marked by high levels of chromatin interaction within these regions and separated by genomic boundaries, across which interaction occurs much less frequently.These domains and boundaries may provide the underlying genomic infrastructure for gene regulation and long range activation or repression of gene expression.Disruption of the boundary regions has been associated with human disease in two types of limb abnormalities and in other small disease specific populations.To date only one study has estimated the impact of TAD boundary deletions in an affected population and that study focused on large, known pathogenic deletions that were likely to disrupt multiple boundaries.In this study, a large scale, quantitative, comparative case-control study design was used to examine the presence of deletions across TAD boundaries by comparing patients with clinical indications for microarray testing to population-based controls.5033 patients with a broad variety of clinical indications for microarray were compared with 312 controls to assess overall deletion burden, enrichment of topologically-associated domain boundary region disruption, and phenotypic trends among patients.A nonparametric t-test was used to assess the difference in the proportion of deletions which span an entire TAD boundary in cases compared to controls.No significant difference was found between cases and controls when both heterozygous and homozygous deletions were compared together.However, cases had significantly more homozygous TADs deletions than controls (p<0.0001).Furthermore, the increase in homozygous TADs in cases could not be explained by the overall number of homozygous deletions.Rare topological domain disruption among the cases was examined to identify candidate TADs deletions associated with phenotypic trends.Chromosome 14q32 was assessed for phenotypic trends and shared genomic properties.These data demonstrate that further analysis is warranted to determine the impact of TAD iii disruption on human disease.The approach used here sets a foundation for clinical interpretation of TAD disruption in a clinical setting.
Author: Jessica Shank
Institution: University of Cincinnati
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2781912818
